Keenan Greg (CIK 2044006) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-10). Recent activity: Sell AUPH (8,069 shares), Buy AUPH (40,586 shares), Sell AUPH (11,552 shares), Sell AUPH (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | Aurinia Pharmaceuticals Inc. (AUPH) | SVP, Chief Medical Officer | Sell | 8,069 | $115,548 |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | SVP, Chief Medical Officer | Buy | 40,586 | $0 |
| 2026-02-03 | Aurinia Pharmaceuticals Inc. (AUPH) | SVP, Chief Medical Officer | Sell | 11,552 | $167,851 |
| 2025-08-05 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Medical Officer | Sell | 20,000 | $210,000 |
来源：SEC Form 4 申报文件 · 截至 2026-03-10